Found: The chairs of several APPGs have supported the application, including global tuberculosis, UHC, vaccinations

Found: The chairs of several APPGs have supported the application, including global tuberculosis, UHC, vaccinations

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State for Foreign, Commonwealth and Development Affairs, what assessment he has made of the implications for his Department's policies of the World Health Organisation's 2023 Global Tuberculosis report; and whether his Department plans to take steps to help support the WHO's End TB Strategy.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The UK Government was pleased to see that the 2023 Global Tuberculosis report showed 7.5 million people were diagnosed and treated for Tuberculosis (TB) in 2022, the highest number since WHO started collecting the data in 1995, and also a slight reduction in the number of people dying from TB, from 1.4 million in 2021 to 1.3 million in 2022. The UK supports the WHO's End TB Strategy through our £1 billion funding to the Global Fund to Fight AIDS, TB and Malaria, other complementary investments to bring down the prices of key TB products and tackle barriers to access, funding to the TB Reach Initiative, and funding for Research and Development, including to the TB Alliance Product Development Partnership.

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State for Foreign, Commonwealth and Development Affairs, with reference to the World Health Organisation's 2023 Global Tuberculosis report, what steps Government is taking to help increase global access to multi-drug resistant tuberculosis treatments.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The UK is committed to ending the Tuberculosis (TB) epidemic. Through our £1 billion funding to the Global Fund to Fight AIDS, Tuberculosis and Malaria's seventh replenishment, the UK will help to provide treatment and care for more than one million people with tuberculosis. In addition we also fund catalytic interventions through Unitaid, the Clinton Health Access Initiative (CHAI) and MedAccess to bring down the prices of new TB products and tackle barriers to widespread access. We also provide funding to TB Reach to support innovative projects towards finding missing Tuberculosis cases.

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State for Foreign, Commonwealth and Development Affairs, with reference to the World Health Organisation's 2023 Global Tuberculosis report, what steps his Department is taking to help increase the number of people diagnosed with tuberculosis globally.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The UK is committed to ending the Tuberculosis (TB) epidemic. Through our £1 billion funding to the Global Fund to Fight AIDS, Tuberculosis and Malaria's seventh replenishment, the UK will help to provide treatment and care for more than one million people with tuberculosis. In addition we also fund catalytic interventions through Unitaid, the Clinton Health Access Initiative (CHAI) and MedAccess to bring down the prices of new TB products and tackle barriers to widespread access. We also provide funding to TB Reach to support innovative projects towards finding missing Tuberculosis cases.

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State, Foreign, Commonwealth and Development Office, , with reference to the World Health Organisation's 2023 Global Tuberculosis report, what steps the Government is taking to help reduce the cost of treatment for people with tuberculosis globally.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The UK is committed to ending the Tuberculosis (TB) epidemic. Through our £1 billion funding to the Global Fund to Fight AIDS, Tuberculosis and Malaria's seventh replenishment, the UK will help to provide treatment and care for more than one million people with tuberculosis. In addition we also fund catalytic interventions through Unitaid, the Clinton Health Access Initiative (CHAI) and MedAccess to bring down the prices of new TB products and tackle barriers to widespread access. We also provide funding to TB Reach to support innovative projects towards finding missing Tuberculosis cases.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish a WHO Multisectoral Accountability Framework for TB following the UN High-level Meeting on the fight against tuberculosis on 22 September 2023.

Answered by Will Quince

The Multisectoral Accountability Framework for Tuberculosis is a World Health Organization (WHO) initiative which includes regular global assessments. The UK Health Security Agency (UKHSA) and the Department are working with WHO’s Global Lead for Multisectoral Engagement and the Director of the Global Tuberculosis Programme on the United Kingdom implementation of the framework. There is currently no plan to publish a separate UK assessment at this time.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment he has made of the steps his Department can take to help tackle the increase in the number of people dying from TB globally as outlined in the World Health Organisation’s 2022 Global Tuberculosis Report.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The World Health Organisation's 2022 Global Tuberculosis Report estimates that 10.6 million people fell ill with TB in 2021, a 4.5 per cent increase from the previous year. The number of people dying from TB rose from 1.5 to 1.6 million, the second successive yearly rise. The report also shows a 3 per cent increase in the burden of drug-resistant TB (DR-TB), with 450,000 new cases of rifampicin-resistant TB (RR-TB) in 2021. These increases follow many years of sustained progress to reduce the burden of TB and reflect the impact of COVID-19 on country health systems.

The UK Government supports the World Health Organisation's End TB strategy towards achieving the Sustainable Development Goal 3.3 target to end the epidemic of tuberculosis by 2030. The UK's £1 billion pledge for the Global Fund to Fight AIDS, TB and Malaria's seventh replenishment will help the Global Fund and its partners provide TB treatment and care for 1.1 million people, screen 20 million people for TB, and provide 42,000 people with treatment for multidrug-resistant TB. In addition to this the Government also supports research and development in to new tools, evidence and medicine to combat TB; catalytic interventions to bring down prices of new products and tackle barriers to widespread access to TB diagnostics and treatments; and provides bilateral support to TB endemic countries to strengthen their health systems.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether his Department is taking steps to provide funding for international programmes to help support people with tuberculosis with the high costs they incur as a consequence of that illness.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The World Health Organisation's 2022 Global Tuberculosis Report estimates that 10.6 million people fell ill with TB in 2021, a 4.5 per cent increase from the previous year. The number of people dying from TB rose from 1.5 to 1.6 million, the second successive yearly rise. The report also shows a 3 per cent increase in the burden of drug-resistant TB (DR-TB), with 450,000 new cases of rifampicin-resistant TB (RR-TB) in 2021. These increases follow many years of sustained progress to reduce the burden of TB and reflect the impact of COVID-19 on country health systems.

The UK Government supports the World Health Organisation's End TB strategy towards achieving the Sustainable Development Goal 3.3 target to end the epidemic of tuberculosis by 2030. The UK's £1 billion pledge for the Global Fund to Fight AIDS, TB and Malaria's seventh replenishment will help the Global Fund and its partners provide TB treatment and care for 1.1 million people, screen 20 million people for TB, and provide 42,000 people with treatment for multidrug-resistant TB. In addition to this the Government also supports research and development in to new tools, evidence and medicine to combat TB; catalytic interventions to bring down prices of new products and tackle barriers to widespread access to TB diagnostics and treatments; and provides bilateral support to TB endemic countries to strengthen their health systems.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to bilaterally facilitate the eradication to TB globally.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The World Health Organisation's 2022 Global Tuberculosis Report estimates that 10.6 million people fell ill with TB in 2021, a 4.5 per cent increase from the previous year. The number of people dying from TB rose from 1.5 to 1.6 million, the second successive yearly rise. The report also shows a 3 per cent increase in the burden of drug-resistant TB (DR-TB), with 450,000 new cases of rifampicin-resistant TB (RR-TB) in 2021. These increases follow many years of sustained progress to reduce the burden of TB and reflect the impact of COVID-19 on country health systems.

The UK Government supports the World Health Organisation's End TB strategy towards achieving the Sustainable Development Goal 3.3 target to end the epidemic of tuberculosis by 2030. The UK's £1 billion pledge for the Global Fund to Fight AIDS, TB and Malaria's seventh replenishment will help the Global Fund and its partners provide TB treatment and care for 1.1 million people, screen 20 million people for TB, and provide 42,000 people with treatment for multidrug-resistant TB. In addition to this the Government also supports research and development in to new tools, evidence and medicine to combat TB; catalytic interventions to bring down prices of new products and tackle barriers to widespread access to TB diagnostics and treatments; and provides bilateral support to TB endemic countries to strengthen their health systems.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps his Department is taking to help ensure TB is eradicated globally by 2030 in line with SDG 3.3.2.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The World Health Organisation's 2022 Global Tuberculosis Report estimates that 10.6 million people fell ill with TB in 2021, a 4.5 per cent increase from the previous year. The number of people dying from TB rose from 1.5 to 1.6 million, the second successive yearly rise. The report also shows a 3 per cent increase in the burden of drug-resistant TB (DR-TB), with 450,000 new cases of rifampicin-resistant TB (RR-TB) in 2021. These increases follow many years of sustained progress to reduce the burden of TB and reflect the impact of COVID-19 on country health systems.

The UK Government supports the World Health Organisation's End TB strategy towards achieving the Sustainable Development Goal 3.3 target to end the epidemic of tuberculosis by 2030. The UK's £1 billion pledge for the Global Fund to Fight AIDS, TB and Malaria's seventh replenishment will help the Global Fund and its partners provide TB treatment and care for 1.1 million people, screen 20 million people for TB, and provide 42,000 people with treatment for multidrug-resistant TB. In addition to this the Government also supports research and development in to new tools, evidence and medicine to combat TB; catalytic interventions to bring down prices of new products and tackle barriers to widespread access to TB diagnostics and treatments; and provides bilateral support to TB endemic countries to strengthen their health systems.

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment he has made of the implications for his policies of the World Health Organisation’s 2022 Global Tuberculosis Report.

Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)

The World Health Organisation's 2022 Global Tuberculosis Report estimates that 10.6 million people fell ill with TB in 2021, a 4.5 per cent increase from the previous year. The number of people dying from TB rose from 1.5 to 1.6 million, the second successive yearly rise. The report also shows a 3 per cent increase in the burden of drug-resistant TB (DR-TB), with 450,000 new cases of rifampicin-resistant TB (RR-TB) in 2021. These increases follow many years of sustained progress to reduce the burden of TB and reflect the impact of COVID-19 on country health systems.

The UK Government supports the World Health Organisation's End TB strategy towards achieving the Sustainable Development Goal 3.3 target to end the epidemic of tuberculosis by 2030. The UK's £1 billion pledge for the Global Fund to Fight AIDS, TB and Malaria's seventh replenishment will help the Global Fund and its partners provide TB treatment and care for 1.1 million people, screen 20 million people for TB, and provide 42,000 people with treatment for multidrug-resistant TB. In addition to this the Government also supports research and development in to new tools, evidence and medicine to combat TB; catalytic interventions to bring down prices of new products and tackle barriers to widespread access to TB diagnostics and treatments; and provides bilateral support to TB endemic countries to strengthen their health systems.

Found: Andrew Mitchell | Foreign, Commonwea lth and Development Office The World Health Organisation's 2022 Global

.@UN have published the modalities document for the 2023 TB HLM. The theme is "Advancing science, finance and innovation, and their benefits, to urgently end the global tuberculosis epidemic, in particular by ensuring equitable access to prevention, testing, treatment and care'

Found: “Global tuberculosis report 2021”. [4] Kim, Y. J., Park, B., & Kang, H. E. (2021).